News
Two leading oral cancer treatment guidelines differ on recurrence and survival predictions
- Author:
- Jim Kling
CAP guidance predicted recurrence and survival, but RCPath guidance did not.
News
Immunotherapy treatment shows promise for resectable liver cancer
- Author:
- Jim Kling
Positive phase 2 results pave the way for phase 3 studies.
News
Rise in oral cancers among young nonsmokers points to immunodeficiency
- Author:
- Jim Kling
A study of 2,073 patients shows nonsmokers have higher mortality rates compared with smokers.
News
Breast density linked to familial breast cancer risk
- Author:
- Jim Kling
Findings underscore the need for mammograms early in high risk premenopausal women.
News
Trial gives new guidance for choosing initial PsA treatment
- Author:
- Jim Kling
Adding the tumor necrosis factor inhibitor adalimumab to methotrexate because of a lack of efficacy or tolerability produced better results than...
News
Untargeted CT scans leads to overdiagnoses in lung cancer
- Author:
- Jim Kling
The dangers of overdiagnosis are counterintuitive, but real.
News
Topical steroid shows promise for EOE
- Author:
- Jim Kling
Formulation designed for the esophagus could replace repurposed inhalants in eosinophilic esophagitis.
News
B-cell depletion overkill?
- Author:
- Jim Kling
B-cell depletion following ocrelizumab or rituximab treatment often lasts longer than 6 months.
News
AGA Clinical Practice Update: Commentary on noninvasive CRC screening
- Author:
- Jim Kling
How to tailor screening based on CRC risk, and how to be sure screening is effective.
News
CV risk biomarkers tentatively identified in psoriatic disease
- Author:
- Jim Kling
Troponin I and NT-proBNP levels were linked to cardiovascular risk independently of the Framingham Risk Score.
News
AGA Clinical Practice Guidelines: Systemic HCC therapy
- Author:
- Jim Kling
New therapies offer plenty of options, but evidence is sparse.
News
Home cognitive therapy looks feasible in MS
- Author:
- Jim Kling
A randomized trial demonstrates how to deliver therapy at home.
News
MRI biomarker to be tested in MS
- Author:
- Jim Kling
A new prospective trial aims to prove that central vein sign can distinguish MS from clinical mimics.
News
MRI with mammogram reduces breast cancer mortality by more than 50% in high-risk women
- Author:
- Jim Kling
In this high-risk study group, annual MRI screenings started at 30 years old, followed by MRI with mammogram at 40 years old.
News
Chemotherapy and radiation before surgery boosts pancreatic cancer survival
- Author:
- Jim Kling
There is a paradigm shift worldwide from upfront surgery to neoadjuvant treatment.